Sam Backenroth

Sam Backenroth is the current Director at DepYmed and was previously the Chief Financial Officer at NeuBase Therapeutics, Inc. Sam has also been a Board Member at DepYmed, Inc. and Vice President of Business Development at Ohr Pharmaceutical. Prior to that, they worked as an Associate in Investment Banking at The Benchmark Company.